COO vs SLS · P/E 36, rev $4.09B vs $1.62B cap
The Cooper Companies, Inc (COO) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
COO currently screens at market cap $14.92B and trailing P/E 36.1. SLS currently screens at market cap $1.62B.
Not investment advice. Open the COO and SLS stock pages for the full models.
Not investment advice.